Related FL Goldman Concerned Over Retail Stocks, Where To Park The Money Short Covering May Be Retail ETF's Best Hope Retail heavyweights on tap for earnings amid disruptive backdrop (Seeking Alpha)
Foot Locker, Inc. (NYSE: FL) is expected to report its first-quarter numbers on May 20, and Susquehanna expects EPS of $1.38, a penny below the Street's view. The brokerage also noted that the retailer is the least affected by Amazon.com, Inc. (NASDAQ: AMZN) within the retail sector.
Top 5 Stocks To Own For 2018: Tuesday Morning Corp.(TUES)
- [By Monica Gerson]
Tuesday Morning (NASDAQ: TUES) shares gained 4.87% to create a new 52-week high of $14.63. Tuesday Morning shares have jumped 110.09% over the past 52 weeks, while the S&P 500 index has gained 18.17% in the same period.
- [By Peter Graham]
Small cap closeout home decor retailer Tuesday Morning Corporation (NASDAQ: TUES) reported Q4 and fiscal 2017 earnings before the market opened on Thursday. Q4net sales were $223.6 million versus $222.8 million as the Company’s sales comparison to the prior year is impacted by the net closure of 20 stores during the current fiscal year.Comparable store sales increased 1.8% compared to the same period a year ago, and were comprised of a 2.6% increase in customer transactions, partially offset by a 0.8% decrease in average ticket. The Company operated 731 stores at the end of the fiscal year, which is a decrease of 20 stores from the prior year period.The net loss was $17.3 million versusa net loss of $3.9 million.
Top 5 Stocks To Own For 2018: Pegasystems Inc.(PEGA)
- [By Steve Symington]
Shares ofPegasystems Inc.(NASDAQ:PEGA) jumped 31.5% in 2016,according to data from S&P Global Market Intelligence, largely thanks to a strong quarterly report from the business management software specialist late in the year.
- [By Demitrios Kalogeropoulos]
As for individual stocks, Snap (NYSE:SNAP) and Pegasystems (NASDAQ:PEGA) made big moves following the companies’ quarterly earnings reports.
Image source: Getty Images.
Top 5 Stocks To Own For 2018: Take-Two Interactive Software, Inc.(TTWO)
- [By John Ballard]
But now we are starting to see game publishers step up with that commitment. Two important new leagues to watch are Activision Blizzard’s (NASDAQ:ATVI) Overwatch League and Take-Two Interactive Software’s (NASDAQ:TTWO)NBA 2K eLeague. Activision Blizzard will soon start selling teams for Overwatch League to prospective owners this year, and the NBA and Take-Two just announced the formation of its own professional e-sports league based on the best-selling NBA 2K franchise.
- [By Lee Jackson]
Take-Two Interactive Software Inc. (NASDAQ: TTWO) saw the CFO at the video gaming company shedding shares this past week. Lainie Goldstein sold 56,167 shares at prices that ranged from $49.27 to $50.01. The total for the sale was posted at $3 million. The stocktraded on Friday at $47.90, so a well-timed sale indeed.
- [By Danny Vena]
With that much revenue at stake, what are the best gaming stocks for investors in 2017? Several companies have exhibited impressive performance over the past several years, and that trend is likely to continue. Top choices in the space includeActivision Blizzard, Inc. (NASDAQ:ATVI), Electronic Arts Inc. (NASDAQ:EA), and Take-Two Interactive (NASDAQ:TTWO).
- [By John Ballard]
Investors interested in the video game industry should find both Electronic Arts (NASDAQ:EA) and Take-Two Interactive Software(NASDAQ:TTWO) appealing. Both are expanding margins as digital revenue opportunities from in-game content and mobile gaming continue to propel the industry forward.
- [By Dan Caplinger]
For video-game maker Take-Two Interactive Software (NASDAQ:TTWO), the timely launch of new installments of franchise game series is critical. That’s why investors briefly panicked late Monday night, when Take-Two said that the much-anticipated Red Dead Redemption 2 would have its release delayed. That put even greater importance on the company’s earnings report to reassure investors of the game-maker’s future.
Top 5 Stocks To Own For 2018: Old National Bancorp Capital Trust I(ONB)
- [By kiplinger]
Old National Bancorp (ONB) is a 181-year-old financial institution with 195 branches, mainly in the Midwest. The stock, which is still down by about one-third from its prerecession high, trades at just 13 times projected 2016 earnings and yields an attractive 3.4%. If interest rates ever rise, the bank should benefit from a widening spread between its cost of funds and the interest rates borrowers pay.It’s a favorite of David Dreman, author of the classic 1980 book Contrarian Investment Strategy. His philosophy: “We believe that the markets are not perfectly efficient.” Some stocks, in other words, are judged by the market to be cheaper than their actual worth.
- [By Ben Levisohn]
The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.
Top 5 Stocks To Own For 2018: Ionis Pharmaceuticals, Inc.(IONS)
- [By Brian Orelli]
Ionis Pharmaceuticals (NASDAQ:IONS) gave investors an update on its pipeline today with a slide deck that contained a whopping 65 entries. The whole presentation is worth a listen, but here are the five slides investors absolutely must see.
- [By Cory Renauer]
Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.
- [By WWW.THESTREET.COM]
Coming up in this episode of Mad Money: Cramer interviews Dr. Stanley Crooke, CEO of Ionis Pharmaceuticals (IONS) . And, here’s Cramer’s read on Trump’s view of China. Plus, don’t miss the Lightning Round. Which stocks in Cramer bullish on?
- [By Ben Levisohn]